UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract P6-19-03: The role of lumpectomy and radiation therapy in men 70 years of age and older with early breast cancer on hormone therapy: A NCDB analysis

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-19-03

2019

Volltextzugriff (PDF)

Hilar cholangiocarcinoma: surgical and endoscopic approaches

Surgical Clinics of North America, 2004-04, Vol.84 (2), p.525-542

2004

Volltextzugriff (PDF)

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

British journal of cancer, 2003-12, Vol.89 (11), p.2110-2115

2003

Volltextzugriff (PDF)

Abstract OT2-02-03: Magnetic nano-device for identification of the breast sentinel nodes – A novel method

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT2-02-03-OT2-02-03

2016

Volltextzugriff (PDF)

Morbidity, mortality, and technical factors of distal pancreatectomy

The American journal of surgery, 2002-03, Vol.183 (3), p.237-241

2002

Volltextzugriff (PDF)

AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2

British journal of cancer, 2003-07, Vol.89 (2), p.391-397

2003

Volltextzugriff (PDF)

Chemosensitization of Pancreatic Cancer by Inhibition of the 26S Proteasome

The Journal of surgical research, 2001-09, Vol.100 (1), p.11-17

2001

Volltextzugriff (PDF)

Inhibition of AKT abrogates chemotherapy- induced NF-κB survival mechanisms: implications for therapy in pancreatic cancer

Journal of the American College of Surgeons, 2004-04, Vol.198 (4), p.591-599

2004

Volltextzugriff (PDF)

Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Cancer chemotherapy and pharmacology, 2005-07, Vol.56 (1), p.46-54

2005

Volltextzugriff (PDF)

Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts

Molecular cancer therapeutics, 2002-12, Vol.1 (14), p.1243

2002

Volltextzugriff (PDF)

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

Cancer chemotherapy and pharmacology, 2004-10, Vol.54 (4), p.343-353

2004

Volltextzugriff (PDF)

Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content

Annals of surgical oncology, 1999-04, Vol.6 (3), p.279-285

1999

Volltextzugriff (PDF)

Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment

Annals of surgical oncology, 2003-11, Vol.10 (9), p.1118-1122

2003

Volltextzugriff (PDF)

Standardization of sentinel lymph node biopsy in breast carcinoma

Cancer, 2005-02, Vol.103 (3), p.444-446

Bold, Richard J.

2005

Volltextzugriff (PDF)

Apoptosis, cancer and cancer therapy

Surgical Oncology, 1997-11, Vol.6 (3), p.133-142

1997

Volltextzugriff (PDF)

Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-08, Vol.49 (2), p.163-170

2005

Volltextzugriff (PDF)

All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines

Pancreas, 1996-03, Vol.12 (2), p.189-195

1996

Volltextzugriff (PDF)

Re: Rectal cancer surgery in the elderly: A multivariate analysis of outcome risk factors, by Bufalari A, Giustozzi G, Burattini MF, et al

Journal of surgical oncology, 2006-03, Vol.93 (3), p.167-168

Bold, Richard J.

2006

Volltextzugriff (PDF)

An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer

The American journal of surgery, 2005-09, Vol.190 (3), p.406-411

2005

Volltextzugriff (PDF)

Patterns of recurrence in extremity liposarcoma : Implications for staging and follow-up

Cancer, 1999, Vol.85 (1), p.85-92

1999

Volltextzugriff (PDF)

Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer

The Journal of surgical research, 2003-07, Vol.113 (1), p.88-95

2003

Volltextzugriff (PDF)

BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines

Cancer, 2001-09, Vol.92 (5), p.1122-1129

2001

Volltextzugriff (PDF)

Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis

Journal of gastrointestinal surgery, 1999-05, Vol.3 (3), p.233-243

1999

Volltextzugriff (PDF)

Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy

Seminars in oncology, 2004-02, Vol.31 (1 Suppl 1), p.40-46

2004

Volltextzugriff (PDF)

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

Annals of surgical oncology, 1998-12, Vol.5 (8), p.681-688

1998

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(79)
Tagungsberichte
(1)

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(70)
Humans
(55)
Surgery
(37)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Oncology
(26)
Female
(20)
Tumor Cells, Cultured
(20)
Male
(19)
Animals
(18)
Tumors
(18)
Middle Aged
(15)
Pancreatic Neoplasms - Pathology
(13)
Aged
(11)
Gastroenterology. Liver. Pancreas. Abdomen
(10)
Mice
(10)
Adult
(9)
Cell Division - Drug Effects
(9)
Apoptosis
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract P6-19-03: The role of lumpectomy and radiation therapy in men 70 years of age and older with early breast cancer on hormone therapy: A NCDB analysis

Hilar cholangiocarcinoma: surgical and endoscopic approaches

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

Abstract OT2-02-03: Magnetic nano-device for identification of the breast sentinel nodes – A novel method

Morbidity, mortality, and technical factors of distal pancreatectomy

AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2

Chemosensitization of Pancreatic Cancer by Inhibition of the 26S Proteasome

Inhibition of AKT abrogates chemotherapy- induced NF-κB survival mechanisms: implications for therapy in pancreatic cancer

Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content

Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment

Standardization of sentinel lymph node biopsy in breast carcinoma

Apoptosis, cancer and cancer therapy

Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer

All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines

Re: Rectal cancer surgery in the elderly: A multivariate analysis of outcome risk factors, by Bufalari A, Giustozzi G, Burattini MF, et al

An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer

Patterns of recurrence in extremity liposarcoma : Implications for staging and follow-up

Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer

BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines

Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis

Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

Suchergebnisse filtern